Cutera Inc (CUTR, Financial), a medical device company, experienced a significant stock drop of 5.27%. The current share price stands at $0.710 with a trading volume of 58,043 shares and a turnover rate of 0.29%. The stock's volatility shows an amplitude of 4.62%.
Recent financial reports indicate that Cutera Inc generated a revenue of $34.38 million, but faced a net loss of $24.68 million, translating to an earnings per share (EPS) of -$1.23. The company's gross profit was reported at $6.27 million with a negative P/E ratio of -0.10. In terms of analyst ratings, 25% of the four institutions rated the stock as a "buy," while 75% recommended a "hold." None suggested a "sell."
The broader medical device sector, which Cutera Inc is part of, saw an overall decline of 0.87%. Among the related stocks, Pavmed Inc, Trisalus Life Sciences Inc, and Volcon Inc showed notable gains. Stocks with high turnover rates included Tenon Medical Inc, Reshape Lifesciences Inc, and Bone Biologics Corp, while Pavmed Inc, Baird Medical Investment Holdings Ltd, and Tenon Medical Inc experienced considerable price swings.
Cutera Inc specializes in designing, developing, and marketing laser and energy-based aesthetic systems globally. Their product line includes brands such as Enlighten, Excel HR, Excel V, Xeo, and Trusculpt 3D, with the majority of their revenue coming from the U.S. The company’s products are designed to safely perform aesthetic procedures, including acne treatment, body contouring, skin rejuvenation, hair removal, and tattoo removal.
